20
Participants
Start Date
October 31, 2025
Primary Completion Date
December 30, 2026
Study Completion Date
December 30, 2028
Capscan
"Participants will be asked to swallow 2 small devices (called Capscan), which will collect samples of intestinal fluid as they move through participants small intestine and colon. This device is not FDA approved but has been deemed to have no significant risk. The investigator can explain how it is designed to work. Participants will also answer surveys about participants quality of life.~Participants in this study will be over after all study procedures are completed."
MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER